The American journal of medicine, 2020-06, Vol.133 (6), p.675-678
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- New Drugs Approved in 2019
- Ist Teil von
- The American journal of medicine, 2020-06, Vol.133 (6), p.675-678
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2020
- Quelle
- Access via ScienceDirect (Elsevier)
- Beschreibungen/Notizen
- In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug approvals were reviewed and approved through an expedited review pathway while 20 of the 48 (41.7%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2019.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0002-9343eISSN: 1555-7162DOI: 10.1016/j.amjmed.2020.01.030Titel-ID: cdi_proquest_miscellaneous_2374341201
- Format
- –
- Schlagworte
- Accelerated approval, Fast track, Food and Drug Administration (FDA), Novel drugs, Priority review